Rafferty Asset Management, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,777,493
-45.4%
139,740
-39.5%
0.01%
-44.4%
Q2 2023$3,253,761
-10.0%
231,091
-1.2%
0.02%
-25.0%
Q1 2023$3,615,485
-12.7%
234,012
-7.4%
0.02%
-31.4%
Q4 2022$4,140,491
+10.8%
252,623
+25.0%
0.04%
-12.5%
Q3 2022$3,738,000
+81.5%
202,053
+29.0%
0.04%
+110.5%
Q2 2022$2,059,000
-47.4%
156,586
-62.9%
0.02%
-17.4%
Q1 2022$3,916,000
-26.9%
422,387
-22.9%
0.02%
-17.9%
Q4 2021$5,354,000
+139.0%
547,997
+731.3%
0.03%
+86.7%
Q3 2021$2,240,000
-16.9%
65,917
-10.5%
0.02%
-11.8%
Q2 2021$2,696,000
-22.2%
73,648
-4.7%
0.02%
-29.2%
Q1 2021$3,464,000
+270.9%
77,263
+372.2%
0.02%
+166.7%
Q4 2020$934,000
-57.3%
16,361
-61.6%
0.01%
-65.4%
Q3 2020$2,187,000
+107.9%
42,630
+142.0%
0.03%
+73.3%
Q2 2020$1,052,000
-49.4%
17,618
-47.3%
0.02%
-53.1%
Q4 2019$2,080,000
+53.8%
33,415
-16.1%
0.03%
+52.4%
Q3 2019$1,352,000
+96.2%
39,848
+30.4%
0.02%
+75.0%
Q2 2019$689,000
-10.2%
30,555
-7.5%
0.01%0.0%
Q1 2019$767,00033,0320.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders